Global Blood Products

Blood Products Comprehensive Study by Type (Whole Blood Collection (System and Reagents), Source Plasma Collection (System and Reagents), Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others), Blood Typing Products (System and Reagents), Others), Application (Immunity, Therapy, Surgery, Other), End-User (Hospital, Blood Station, Other) Players and Region - Global Market Outlook to 2026

Blood Products Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
The study covers a detailed analysis segmented by key business segments i.e. by type (Whole Blood Collection (System and Reagents), Source Plasma Collection (System and Reagents), Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others), Blood Typing Products (System and Reagents) and Others) , by application (Immunity, Therapy, Surgery and Other) and major geographies. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Blood Products market throughout the predicted period.

What is Blood Products?
Blood products are also classified as blood components, it is made from human blood, which is prepared while blood transfusion. Some of the major products that are built during transfusion are red cells, platelets, and fresh frozen plasma among others. All these blood products are very necessary while a surgery, it helps in making the body immune and also protect from various kinds of diseases. Plasma is one of the major components of blood, from which certain blood products are made, so it can vital to the regulation of body functions. These blood products are an effective therapeutic treatment from various battling chronic diseases

The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Blood Products market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, including:
  • Baxter (United States)
  • CSL (Australia)
  • Grifols (Spain)
  • Octapharma (Switzerland)
  • BPL (United Kingdom)
  • Kedrion (ITALY)
  • Mitsubishi Tanabe (Japan)
  • CBOP (India)
  • Hualan Bio (China)


According to Food and Drugs, The Center for Biologics Evaluation and Research (CBER) regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components, such as clotting factors, and establishes standards for the products themselves. CBER also regulates related products such as cell separation devices, blood collection containers and HIV screening tests that are used to prepare blood products or to ensure the safety of the blood supply. CBER develops and enforces quality standards, inspects blood establishments and monitors reports of errors, accidents and adverse clinical events.

Market Trend
Rise in Technology at Plasma Collection Centers to Collect Plasma and Record Patient History
Restraints
  • High Cost of these Blood Products

Opportunities
Increase in the Number of Geriatric Population World Widely and High Demand for Safe Blood Due to High Prevalence of Transfusion Transmissible Infections Such as HIV, Hepatitis B across the World

Key highlights of the Global Blood Products market Study:
• CAGR of the market during the forecast period 2020-2026
• In-depth information on growth factors that will accelerate the Blood Products market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global Blood Products market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Blood Products Players

Transformation and Important Trigegrs:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Products market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Products market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Potential Investors, Government Bodies and Associations, Up and Down Stream Vendors, Private Research Organizations, Suppliers and Distributors, Pharmaceuticals Companies and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Whole Blood Collection (System and Reagents)
  • Source Plasma Collection (System and Reagents)
  • Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others)
  • Blood Typing Products (System and Reagents)
  • Others
By Application
  • Immunity
  • Therapy
  • Surgery
  • Other
By End-User
  • Hospital
  • Blood Station
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand of Immunoglobulin for the Treatment of Immunodeficiency
      • 3.2.2. Prevalence of Chronic Diseases Globally
    • 3.3. Market Challenges
      • 3.3.1. Issues Related While Blood Diffusion and Transfusion
      • 3.3.2. Concern Related to the Storage of these Blood Products
    • 3.4. Market Trends
      • 3.4.1. Rise in Technology at Plasma Collection Centers to Collect Plasma and Record Patient History
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Products, by Type, Application, End-User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blood Products (Value)
      • 5.2.1. Global Blood Products by: Type (Value)
        • 5.2.1.1. Whole Blood Collection (System and Reagents)
        • 5.2.1.2. Source Plasma Collection (System and Reagents)
        • 5.2.1.3. Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others)
        • 5.2.1.4. Blood Typing Products (System and Reagents)
        • 5.2.1.5. Others
      • 5.2.2. Global Blood Products by: Application (Value)
        • 5.2.2.1. Immunity
        • 5.2.2.2. Therapy
        • 5.2.2.3. Surgery
        • 5.2.2.4. Other
      • 5.2.3. Global Blood Products by: End-User (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Blood Station
        • 5.2.3.3. Other
      • 5.2.4. Global Blood Products Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blood Products (Volume)
      • 5.3.1. Global Blood Products by: Type (Volume)
        • 5.3.1.1. Whole Blood Collection (System and Reagents)
        • 5.3.1.2. Source Plasma Collection (System and Reagents)
        • 5.3.1.3. Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others)
        • 5.3.1.4. Blood Typing Products (System and Reagents)
        • 5.3.1.5. Others
      • 5.3.2. Global Blood Products by: Application (Volume)
        • 5.3.2.1. Immunity
        • 5.3.2.2. Therapy
        • 5.3.2.3. Surgery
        • 5.3.2.4. Other
      • 5.3.3. Global Blood Products by: End-User (Volume)
        • 5.3.3.1. Hospital
        • 5.3.3.2. Blood Station
        • 5.3.3.3. Other
      • 5.3.4. Global Blood Products Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Blood Products (Price)
      • 5.4.1. Global Blood Products by: Type (Price)
  • 6. Blood Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CSL (Australia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grifols (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Octapharma (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BPL (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Kedrion (ITALY)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mitsubishi Tanabe (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CBOP (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hualan Bio (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Blood Products Sale, by Type, Application, End-User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blood Products (Value)
      • 7.2.1. Global Blood Products by: Type (Value)
        • 7.2.1.1. Whole Blood Collection (System and Reagents)
        • 7.2.1.2. Source Plasma Collection (System and Reagents)
        • 7.2.1.3. Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others)
        • 7.2.1.4. Blood Typing Products (System and Reagents)
        • 7.2.1.5. Others
      • 7.2.2. Global Blood Products by: Application (Value)
        • 7.2.2.1. Immunity
        • 7.2.2.2. Therapy
        • 7.2.2.3. Surgery
        • 7.2.2.4. Other
      • 7.2.3. Global Blood Products by: End-User (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Blood Station
        • 7.2.3.3. Other
      • 7.2.4. Global Blood Products Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blood Products (Volume)
      • 7.3.1. Global Blood Products by: Type (Volume)
        • 7.3.1.1. Whole Blood Collection (System and Reagents)
        • 7.3.1.2. Source Plasma Collection (System and Reagents)
        • 7.3.1.3. Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others)
        • 7.3.1.4. Blood Typing Products (System and Reagents)
        • 7.3.1.5. Others
      • 7.3.2. Global Blood Products by: Application (Volume)
        • 7.3.2.1. Immunity
        • 7.3.2.2. Therapy
        • 7.3.2.3. Surgery
        • 7.3.2.4. Other
      • 7.3.3. Global Blood Products by: End-User (Volume)
        • 7.3.3.1. Hospital
        • 7.3.3.2. Blood Station
        • 7.3.3.3. Other
      • 7.3.4. Global Blood Products Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Blood Products (Price)
      • 7.4.1. Global Blood Products by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Products: by Type(USD Million)
  • Table 2. Blood Products Whole Blood Collection (System and Reagents) , by Region USD Million (2015-2020)
  • Table 3. Blood Products Source Plasma Collection (System and Reagents) , by Region USD Million (2015-2020)
  • Table 4. Blood Products Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others) , by Region USD Million (2015-2020)
  • Table 5. Blood Products Blood Typing Products (System and Reagents) , by Region USD Million (2015-2020)
  • Table 6. Blood Products Others , by Region USD Million (2015-2020)
  • Table 7. Blood Products: by Application(USD Million)
  • Table 8. Blood Products Immunity , by Region USD Million (2015-2020)
  • Table 9. Blood Products Therapy , by Region USD Million (2015-2020)
  • Table 10. Blood Products Surgery , by Region USD Million (2015-2020)
  • Table 11. Blood Products Other , by Region USD Million (2015-2020)
  • Table 12. Blood Products: by End-User(USD Million)
  • Table 13. Blood Products Hospital , by Region USD Million (2015-2020)
  • Table 14. Blood Products Blood Station , by Region USD Million (2015-2020)
  • Table 15. Blood Products Other , by Region USD Million (2015-2020)
  • Table 16. South America Blood Products, by Country USD Million (2015-2020)
  • Table 17. South America Blood Products, by Type USD Million (2015-2020)
  • Table 18. South America Blood Products, by Application USD Million (2015-2020)
  • Table 19. South America Blood Products, by End-User USD Million (2015-2020)
  • Table 20. Brazil Blood Products, by Type USD Million (2015-2020)
  • Table 21. Brazil Blood Products, by Application USD Million (2015-2020)
  • Table 22. Brazil Blood Products, by End-User USD Million (2015-2020)
  • Table 23. Argentina Blood Products, by Type USD Million (2015-2020)
  • Table 24. Argentina Blood Products, by Application USD Million (2015-2020)
  • Table 25. Argentina Blood Products, by End-User USD Million (2015-2020)
  • Table 26. Rest of South America Blood Products, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Blood Products, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Blood Products, by End-User USD Million (2015-2020)
  • Table 29. Asia Pacific Blood Products, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Blood Products, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Blood Products, by Application USD Million (2015-2020)
  • Table 32. Asia Pacific Blood Products, by End-User USD Million (2015-2020)
  • Table 33. China Blood Products, by Type USD Million (2015-2020)
  • Table 34. China Blood Products, by Application USD Million (2015-2020)
  • Table 35. China Blood Products, by End-User USD Million (2015-2020)
  • Table 36. Japan Blood Products, by Type USD Million (2015-2020)
  • Table 37. Japan Blood Products, by Application USD Million (2015-2020)
  • Table 38. Japan Blood Products, by End-User USD Million (2015-2020)
  • Table 39. India Blood Products, by Type USD Million (2015-2020)
  • Table 40. India Blood Products, by Application USD Million (2015-2020)
  • Table 41. India Blood Products, by End-User USD Million (2015-2020)
  • Table 42. South Korea Blood Products, by Type USD Million (2015-2020)
  • Table 43. South Korea Blood Products, by Application USD Million (2015-2020)
  • Table 44. South Korea Blood Products, by End-User USD Million (2015-2020)
  • Table 45. Taiwan Blood Products, by Type USD Million (2015-2020)
  • Table 46. Taiwan Blood Products, by Application USD Million (2015-2020)
  • Table 47. Taiwan Blood Products, by End-User USD Million (2015-2020)
  • Table 48. Australia Blood Products, by Type USD Million (2015-2020)
  • Table 49. Australia Blood Products, by Application USD Million (2015-2020)
  • Table 50. Australia Blood Products, by End-User USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Blood Products, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Blood Products, by Application USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Blood Products, by End-User USD Million (2015-2020)
  • Table 54. Europe Blood Products, by Country USD Million (2015-2020)
  • Table 55. Europe Blood Products, by Type USD Million (2015-2020)
  • Table 56. Europe Blood Products, by Application USD Million (2015-2020)
  • Table 57. Europe Blood Products, by End-User USD Million (2015-2020)
  • Table 58. Germany Blood Products, by Type USD Million (2015-2020)
  • Table 59. Germany Blood Products, by Application USD Million (2015-2020)
  • Table 60. Germany Blood Products, by End-User USD Million (2015-2020)
  • Table 61. France Blood Products, by Type USD Million (2015-2020)
  • Table 62. France Blood Products, by Application USD Million (2015-2020)
  • Table 63. France Blood Products, by End-User USD Million (2015-2020)
  • Table 64. Italy Blood Products, by Type USD Million (2015-2020)
  • Table 65. Italy Blood Products, by Application USD Million (2015-2020)
  • Table 66. Italy Blood Products, by End-User USD Million (2015-2020)
  • Table 67. United Kingdom Blood Products, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Blood Products, by Application USD Million (2015-2020)
  • Table 69. United Kingdom Blood Products, by End-User USD Million (2015-2020)
  • Table 70. Netherlands Blood Products, by Type USD Million (2015-2020)
  • Table 71. Netherlands Blood Products, by Application USD Million (2015-2020)
  • Table 72. Netherlands Blood Products, by End-User USD Million (2015-2020)
  • Table 73. Rest of Europe Blood Products, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Blood Products, by Application USD Million (2015-2020)
  • Table 75. Rest of Europe Blood Products, by End-User USD Million (2015-2020)
  • Table 76. MEA Blood Products, by Country USD Million (2015-2020)
  • Table 77. MEA Blood Products, by Type USD Million (2015-2020)
  • Table 78. MEA Blood Products, by Application USD Million (2015-2020)
  • Table 79. MEA Blood Products, by End-User USD Million (2015-2020)
  • Table 80. Middle East Blood Products, by Type USD Million (2015-2020)
  • Table 81. Middle East Blood Products, by Application USD Million (2015-2020)
  • Table 82. Middle East Blood Products, by End-User USD Million (2015-2020)
  • Table 83. Africa Blood Products, by Type USD Million (2015-2020)
  • Table 84. Africa Blood Products, by Application USD Million (2015-2020)
  • Table 85. Africa Blood Products, by End-User USD Million (2015-2020)
  • Table 86. North America Blood Products, by Country USD Million (2015-2020)
  • Table 87. North America Blood Products, by Type USD Million (2015-2020)
  • Table 88. North America Blood Products, by Application USD Million (2015-2020)
  • Table 89. North America Blood Products, by End-User USD Million (2015-2020)
  • Table 90. United States Blood Products, by Type USD Million (2015-2020)
  • Table 91. United States Blood Products, by Application USD Million (2015-2020)
  • Table 92. United States Blood Products, by End-User USD Million (2015-2020)
  • Table 93. Canada Blood Products, by Type USD Million (2015-2020)
  • Table 94. Canada Blood Products, by Application USD Million (2015-2020)
  • Table 95. Canada Blood Products, by End-User USD Million (2015-2020)
  • Table 96. Mexico Blood Products, by Type USD Million (2015-2020)
  • Table 97. Mexico Blood Products, by Application USD Million (2015-2020)
  • Table 98. Mexico Blood Products, by End-User USD Million (2015-2020)
  • Table 99. Blood Products Sales: by Type(Unit)
  • Table 100. Blood Products Sales Whole Blood Collection (System and Reagents) , by Region Unit (2015-2020)
  • Table 101. Blood Products Sales Source Plasma Collection (System and Reagents) , by Region Unit (2015-2020)
  • Table 102. Blood Products Sales Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others) , by Region Unit (2015-2020)
  • Table 103. Blood Products Sales Blood Typing Products (System and Reagents) , by Region Unit (2015-2020)
  • Table 104. Blood Products Sales Others , by Region Unit (2015-2020)
  • Table 105. Blood Products Sales: by Application(Unit)
  • Table 106. Blood Products Sales Immunity , by Region Unit (2015-2020)
  • Table 107. Blood Products Sales Therapy , by Region Unit (2015-2020)
  • Table 108. Blood Products Sales Surgery , by Region Unit (2015-2020)
  • Table 109. Blood Products Sales Other , by Region Unit (2015-2020)
  • Table 110. Blood Products Sales: by End-User(Unit)
  • Table 111. Blood Products Sales Hospital , by Region Unit (2015-2020)
  • Table 112. Blood Products Sales Blood Station , by Region Unit (2015-2020)
  • Table 113. Blood Products Sales Other , by Region Unit (2015-2020)
  • Table 114. South America Blood Products Sales, by Country Unit (2015-2020)
  • Table 115. South America Blood Products Sales, by Type Unit (2015-2020)
  • Table 116. South America Blood Products Sales, by Application Unit (2015-2020)
  • Table 117. South America Blood Products Sales, by End-User Unit (2015-2020)
  • Table 118. Brazil Blood Products Sales, by Type Unit (2015-2020)
  • Table 119. Brazil Blood Products Sales, by Application Unit (2015-2020)
  • Table 120. Brazil Blood Products Sales, by End-User Unit (2015-2020)
  • Table 121. Argentina Blood Products Sales, by Type Unit (2015-2020)
  • Table 122. Argentina Blood Products Sales, by Application Unit (2015-2020)
  • Table 123. Argentina Blood Products Sales, by End-User Unit (2015-2020)
  • Table 124. Rest of South America Blood Products Sales, by Type Unit (2015-2020)
  • Table 125. Rest of South America Blood Products Sales, by Application Unit (2015-2020)
  • Table 126. Rest of South America Blood Products Sales, by End-User Unit (2015-2020)
  • Table 127. Asia Pacific Blood Products Sales, by Country Unit (2015-2020)
  • Table 128. Asia Pacific Blood Products Sales, by Type Unit (2015-2020)
  • Table 129. Asia Pacific Blood Products Sales, by Application Unit (2015-2020)
  • Table 130. Asia Pacific Blood Products Sales, by End-User Unit (2015-2020)
  • Table 131. China Blood Products Sales, by Type Unit (2015-2020)
  • Table 132. China Blood Products Sales, by Application Unit (2015-2020)
  • Table 133. China Blood Products Sales, by End-User Unit (2015-2020)
  • Table 134. Japan Blood Products Sales, by Type Unit (2015-2020)
  • Table 135. Japan Blood Products Sales, by Application Unit (2015-2020)
  • Table 136. Japan Blood Products Sales, by End-User Unit (2015-2020)
  • Table 137. India Blood Products Sales, by Type Unit (2015-2020)
  • Table 138. India Blood Products Sales, by Application Unit (2015-2020)
  • Table 139. India Blood Products Sales, by End-User Unit (2015-2020)
  • Table 140. South Korea Blood Products Sales, by Type Unit (2015-2020)
  • Table 141. South Korea Blood Products Sales, by Application Unit (2015-2020)
  • Table 142. South Korea Blood Products Sales, by End-User Unit (2015-2020)
  • Table 143. Taiwan Blood Products Sales, by Type Unit (2015-2020)
  • Table 144. Taiwan Blood Products Sales, by Application Unit (2015-2020)
  • Table 145. Taiwan Blood Products Sales, by End-User Unit (2015-2020)
  • Table 146. Australia Blood Products Sales, by Type Unit (2015-2020)
  • Table 147. Australia Blood Products Sales, by Application Unit (2015-2020)
  • Table 148. Australia Blood Products Sales, by End-User Unit (2015-2020)
  • Table 149. Rest of Asia-Pacific Blood Products Sales, by Type Unit (2015-2020)
  • Table 150. Rest of Asia-Pacific Blood Products Sales, by Application Unit (2015-2020)
  • Table 151. Rest of Asia-Pacific Blood Products Sales, by End-User Unit (2015-2020)
  • Table 152. Europe Blood Products Sales, by Country Unit (2015-2020)
  • Table 153. Europe Blood Products Sales, by Type Unit (2015-2020)
  • Table 154. Europe Blood Products Sales, by Application Unit (2015-2020)
  • Table 155. Europe Blood Products Sales, by End-User Unit (2015-2020)
  • Table 156. Germany Blood Products Sales, by Type Unit (2015-2020)
  • Table 157. Germany Blood Products Sales, by Application Unit (2015-2020)
  • Table 158. Germany Blood Products Sales, by End-User Unit (2015-2020)
  • Table 159. France Blood Products Sales, by Type Unit (2015-2020)
  • Table 160. France Blood Products Sales, by Application Unit (2015-2020)
  • Table 161. France Blood Products Sales, by End-User Unit (2015-2020)
  • Table 162. Italy Blood Products Sales, by Type Unit (2015-2020)
  • Table 163. Italy Blood Products Sales, by Application Unit (2015-2020)
  • Table 164. Italy Blood Products Sales, by End-User Unit (2015-2020)
  • Table 165. United Kingdom Blood Products Sales, by Type Unit (2015-2020)
  • Table 166. United Kingdom Blood Products Sales, by Application Unit (2015-2020)
  • Table 167. United Kingdom Blood Products Sales, by End-User Unit (2015-2020)
  • Table 168. Netherlands Blood Products Sales, by Type Unit (2015-2020)
  • Table 169. Netherlands Blood Products Sales, by Application Unit (2015-2020)
  • Table 170. Netherlands Blood Products Sales, by End-User Unit (2015-2020)
  • Table 171. Rest of Europe Blood Products Sales, by Type Unit (2015-2020)
  • Table 172. Rest of Europe Blood Products Sales, by Application Unit (2015-2020)
  • Table 173. Rest of Europe Blood Products Sales, by End-User Unit (2015-2020)
  • Table 174. MEA Blood Products Sales, by Country Unit (2015-2020)
  • Table 175. MEA Blood Products Sales, by Type Unit (2015-2020)
  • Table 176. MEA Blood Products Sales, by Application Unit (2015-2020)
  • Table 177. MEA Blood Products Sales, by End-User Unit (2015-2020)
  • Table 178. Middle East Blood Products Sales, by Type Unit (2015-2020)
  • Table 179. Middle East Blood Products Sales, by Application Unit (2015-2020)
  • Table 180. Middle East Blood Products Sales, by End-User Unit (2015-2020)
  • Table 181. Africa Blood Products Sales, by Type Unit (2015-2020)
  • Table 182. Africa Blood Products Sales, by Application Unit (2015-2020)
  • Table 183. Africa Blood Products Sales, by End-User Unit (2015-2020)
  • Table 184. North America Blood Products Sales, by Country Unit (2015-2020)
  • Table 185. North America Blood Products Sales, by Type Unit (2015-2020)
  • Table 186. North America Blood Products Sales, by Application Unit (2015-2020)
  • Table 187. North America Blood Products Sales, by End-User Unit (2015-2020)
  • Table 188. United States Blood Products Sales, by Type Unit (2015-2020)
  • Table 189. United States Blood Products Sales, by Application Unit (2015-2020)
  • Table 190. United States Blood Products Sales, by End-User Unit (2015-2020)
  • Table 191. Canada Blood Products Sales, by Type Unit (2015-2020)
  • Table 192. Canada Blood Products Sales, by Application Unit (2015-2020)
  • Table 193. Canada Blood Products Sales, by End-User Unit (2015-2020)
  • Table 194. Mexico Blood Products Sales, by Type Unit (2015-2020)
  • Table 195. Mexico Blood Products Sales, by Application Unit (2015-2020)
  • Table 196. Mexico Blood Products Sales, by End-User Unit (2015-2020)
  • Table 197. Blood Products: by Type(USD/Units)
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Blood Products: by Type(USD Million)
  • Table 208. Blood Products Whole Blood Collection (System and Reagents) , by Region USD Million (2021-2026)
  • Table 209. Blood Products Source Plasma Collection (System and Reagents) , by Region USD Million (2021-2026)
  • Table 210. Blood Products Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others) , by Region USD Million (2021-2026)
  • Table 211. Blood Products Blood Typing Products (System and Reagents) , by Region USD Million (2021-2026)
  • Table 212. Blood Products Others , by Region USD Million (2021-2026)
  • Table 213. Blood Products: by Application(USD Million)
  • Table 214. Blood Products Immunity , by Region USD Million (2021-2026)
  • Table 215. Blood Products Therapy , by Region USD Million (2021-2026)
  • Table 216. Blood Products Surgery , by Region USD Million (2021-2026)
  • Table 217. Blood Products Other , by Region USD Million (2021-2026)
  • Table 218. Blood Products: by End-User(USD Million)
  • Table 219. Blood Products Hospital , by Region USD Million (2021-2026)
  • Table 220. Blood Products Blood Station , by Region USD Million (2021-2026)
  • Table 221. Blood Products Other , by Region USD Million (2021-2026)
  • Table 222. South America Blood Products, by Country USD Million (2021-2026)
  • Table 223. South America Blood Products, by Type USD Million (2021-2026)
  • Table 224. South America Blood Products, by Application USD Million (2021-2026)
  • Table 225. South America Blood Products, by End-User USD Million (2021-2026)
  • Table 226. Brazil Blood Products, by Type USD Million (2021-2026)
  • Table 227. Brazil Blood Products, by Application USD Million (2021-2026)
  • Table 228. Brazil Blood Products, by End-User USD Million (2021-2026)
  • Table 229. Argentina Blood Products, by Type USD Million (2021-2026)
  • Table 230. Argentina Blood Products, by Application USD Million (2021-2026)
  • Table 231. Argentina Blood Products, by End-User USD Million (2021-2026)
  • Table 232. Rest of South America Blood Products, by Type USD Million (2021-2026)
  • Table 233. Rest of South America Blood Products, by Application USD Million (2021-2026)
  • Table 234. Rest of South America Blood Products, by End-User USD Million (2021-2026)
  • Table 235. Asia Pacific Blood Products, by Country USD Million (2021-2026)
  • Table 236. Asia Pacific Blood Products, by Type USD Million (2021-2026)
  • Table 237. Asia Pacific Blood Products, by Application USD Million (2021-2026)
  • Table 238. Asia Pacific Blood Products, by End-User USD Million (2021-2026)
  • Table 239. China Blood Products, by Type USD Million (2021-2026)
  • Table 240. China Blood Products, by Application USD Million (2021-2026)
  • Table 241. China Blood Products, by End-User USD Million (2021-2026)
  • Table 242. Japan Blood Products, by Type USD Million (2021-2026)
  • Table 243. Japan Blood Products, by Application USD Million (2021-2026)
  • Table 244. Japan Blood Products, by End-User USD Million (2021-2026)
  • Table 245. India Blood Products, by Type USD Million (2021-2026)
  • Table 246. India Blood Products, by Application USD Million (2021-2026)
  • Table 247. India Blood Products, by End-User USD Million (2021-2026)
  • Table 248. South Korea Blood Products, by Type USD Million (2021-2026)
  • Table 249. South Korea Blood Products, by Application USD Million (2021-2026)
  • Table 250. South Korea Blood Products, by End-User USD Million (2021-2026)
  • Table 251. Taiwan Blood Products, by Type USD Million (2021-2026)
  • Table 252. Taiwan Blood Products, by Application USD Million (2021-2026)
  • Table 253. Taiwan Blood Products, by End-User USD Million (2021-2026)
  • Table 254. Australia Blood Products, by Type USD Million (2021-2026)
  • Table 255. Australia Blood Products, by Application USD Million (2021-2026)
  • Table 256. Australia Blood Products, by End-User USD Million (2021-2026)
  • Table 257. Rest of Asia-Pacific Blood Products, by Type USD Million (2021-2026)
  • Table 258. Rest of Asia-Pacific Blood Products, by Application USD Million (2021-2026)
  • Table 259. Rest of Asia-Pacific Blood Products, by End-User USD Million (2021-2026)
  • Table 260. Europe Blood Products, by Country USD Million (2021-2026)
  • Table 261. Europe Blood Products, by Type USD Million (2021-2026)
  • Table 262. Europe Blood Products, by Application USD Million (2021-2026)
  • Table 263. Europe Blood Products, by End-User USD Million (2021-2026)
  • Table 264. Germany Blood Products, by Type USD Million (2021-2026)
  • Table 265. Germany Blood Products, by Application USD Million (2021-2026)
  • Table 266. Germany Blood Products, by End-User USD Million (2021-2026)
  • Table 267. France Blood Products, by Type USD Million (2021-2026)
  • Table 268. France Blood Products, by Application USD Million (2021-2026)
  • Table 269. France Blood Products, by End-User USD Million (2021-2026)
  • Table 270. Italy Blood Products, by Type USD Million (2021-2026)
  • Table 271. Italy Blood Products, by Application USD Million (2021-2026)
  • Table 272. Italy Blood Products, by End-User USD Million (2021-2026)
  • Table 273. United Kingdom Blood Products, by Type USD Million (2021-2026)
  • Table 274. United Kingdom Blood Products, by Application USD Million (2021-2026)
  • Table 275. United Kingdom Blood Products, by End-User USD Million (2021-2026)
  • Table 276. Netherlands Blood Products, by Type USD Million (2021-2026)
  • Table 277. Netherlands Blood Products, by Application USD Million (2021-2026)
  • Table 278. Netherlands Blood Products, by End-User USD Million (2021-2026)
  • Table 279. Rest of Europe Blood Products, by Type USD Million (2021-2026)
  • Table 280. Rest of Europe Blood Products, by Application USD Million (2021-2026)
  • Table 281. Rest of Europe Blood Products, by End-User USD Million (2021-2026)
  • Table 282. MEA Blood Products, by Country USD Million (2021-2026)
  • Table 283. MEA Blood Products, by Type USD Million (2021-2026)
  • Table 284. MEA Blood Products, by Application USD Million (2021-2026)
  • Table 285. MEA Blood Products, by End-User USD Million (2021-2026)
  • Table 286. Middle East Blood Products, by Type USD Million (2021-2026)
  • Table 287. Middle East Blood Products, by Application USD Million (2021-2026)
  • Table 288. Middle East Blood Products, by End-User USD Million (2021-2026)
  • Table 289. Africa Blood Products, by Type USD Million (2021-2026)
  • Table 290. Africa Blood Products, by Application USD Million (2021-2026)
  • Table 291. Africa Blood Products, by End-User USD Million (2021-2026)
  • Table 292. North America Blood Products, by Country USD Million (2021-2026)
  • Table 293. North America Blood Products, by Type USD Million (2021-2026)
  • Table 294. North America Blood Products, by Application USD Million (2021-2026)
  • Table 295. North America Blood Products, by End-User USD Million (2021-2026)
  • Table 296. United States Blood Products, by Type USD Million (2021-2026)
  • Table 297. United States Blood Products, by Application USD Million (2021-2026)
  • Table 298. United States Blood Products, by End-User USD Million (2021-2026)
  • Table 299. Canada Blood Products, by Type USD Million (2021-2026)
  • Table 300. Canada Blood Products, by Application USD Million (2021-2026)
  • Table 301. Canada Blood Products, by End-User USD Million (2021-2026)
  • Table 302. Mexico Blood Products, by Type USD Million (2021-2026)
  • Table 303. Mexico Blood Products, by Application USD Million (2021-2026)
  • Table 304. Mexico Blood Products, by End-User USD Million (2021-2026)
  • Table 305. Blood Products Sales: by Type(Unit)
  • Table 306. Blood Products Sales Whole Blood Collection (System and Reagents) , by Region Unit (2021-2026)
  • Table 307. Blood Products Sales Source Plasma Collection (System and Reagents) , by Region Unit (2021-2026)
  • Table 308. Blood Products Sales Blood Therapeutics (IVIG, Albumin, Factor VIII, XI and Others) , by Region Unit (2021-2026)
  • Table 309. Blood Products Sales Blood Typing Products (System and Reagents) , by Region Unit (2021-2026)
  • Table 310. Blood Products Sales Others , by Region Unit (2021-2026)
  • Table 311. Blood Products Sales: by Application(Unit)
  • Table 312. Blood Products Sales Immunity , by Region Unit (2021-2026)
  • Table 313. Blood Products Sales Therapy , by Region Unit (2021-2026)
  • Table 314. Blood Products Sales Surgery , by Region Unit (2021-2026)
  • Table 315. Blood Products Sales Other , by Region Unit (2021-2026)
  • Table 316. Blood Products Sales: by End-User(Unit)
  • Table 317. Blood Products Sales Hospital , by Region Unit (2021-2026)
  • Table 318. Blood Products Sales Blood Station , by Region Unit (2021-2026)
  • Table 319. Blood Products Sales Other , by Region Unit (2021-2026)
  • Table 320. South America Blood Products Sales, by Country Unit (2021-2026)
  • Table 321. South America Blood Products Sales, by Type Unit (2021-2026)
  • Table 322. South America Blood Products Sales, by Application Unit (2021-2026)
  • Table 323. South America Blood Products Sales, by End-User Unit (2021-2026)
  • Table 324. Brazil Blood Products Sales, by Type Unit (2021-2026)
  • Table 325. Brazil Blood Products Sales, by Application Unit (2021-2026)
  • Table 326. Brazil Blood Products Sales, by End-User Unit (2021-2026)
  • Table 327. Argentina Blood Products Sales, by Type Unit (2021-2026)
  • Table 328. Argentina Blood Products Sales, by Application Unit (2021-2026)
  • Table 329. Argentina Blood Products Sales, by End-User Unit (2021-2026)
  • Table 330. Rest of South America Blood Products Sales, by Type Unit (2021-2026)
  • Table 331. Rest of South America Blood Products Sales, by Application Unit (2021-2026)
  • Table 332. Rest of South America Blood Products Sales, by End-User Unit (2021-2026)
  • Table 333. Asia Pacific Blood Products Sales, by Country Unit (2021-2026)
  • Table 334. Asia Pacific Blood Products Sales, by Type Unit (2021-2026)
  • Table 335. Asia Pacific Blood Products Sales, by Application Unit (2021-2026)
  • Table 336. Asia Pacific Blood Products Sales, by End-User Unit (2021-2026)
  • Table 337. China Blood Products Sales, by Type Unit (2021-2026)
  • Table 338. China Blood Products Sales, by Application Unit (2021-2026)
  • Table 339. China Blood Products Sales, by End-User Unit (2021-2026)
  • Table 340. Japan Blood Products Sales, by Type Unit (2021-2026)
  • Table 341. Japan Blood Products Sales, by Application Unit (2021-2026)
  • Table 342. Japan Blood Products Sales, by End-User Unit (2021-2026)
  • Table 343. India Blood Products Sales, by Type Unit (2021-2026)
  • Table 344. India Blood Products Sales, by Application Unit (2021-2026)
  • Table 345. India Blood Products Sales, by End-User Unit (2021-2026)
  • Table 346. South Korea Blood Products Sales, by Type Unit (2021-2026)
  • Table 347. South Korea Blood Products Sales, by Application Unit (2021-2026)
  • Table 348. South Korea Blood Products Sales, by End-User Unit (2021-2026)
  • Table 349. Taiwan Blood Products Sales, by Type Unit (2021-2026)
  • Table 350. Taiwan Blood Products Sales, by Application Unit (2021-2026)
  • Table 351. Taiwan Blood Products Sales, by End-User Unit (2021-2026)
  • Table 352. Australia Blood Products Sales, by Type Unit (2021-2026)
  • Table 353. Australia Blood Products Sales, by Application Unit (2021-2026)
  • Table 354. Australia Blood Products Sales, by End-User Unit (2021-2026)
  • Table 355. Rest of Asia-Pacific Blood Products Sales, by Type Unit (2021-2026)
  • Table 356. Rest of Asia-Pacific Blood Products Sales, by Application Unit (2021-2026)
  • Table 357. Rest of Asia-Pacific Blood Products Sales, by End-User Unit (2021-2026)
  • Table 358. Europe Blood Products Sales, by Country Unit (2021-2026)
  • Table 359. Europe Blood Products Sales, by Type Unit (2021-2026)
  • Table 360. Europe Blood Products Sales, by Application Unit (2021-2026)
  • Table 361. Europe Blood Products Sales, by End-User Unit (2021-2026)
  • Table 362. Germany Blood Products Sales, by Type Unit (2021-2026)
  • Table 363. Germany Blood Products Sales, by Application Unit (2021-2026)
  • Table 364. Germany Blood Products Sales, by End-User Unit (2021-2026)
  • Table 365. France Blood Products Sales, by Type Unit (2021-2026)
  • Table 366. France Blood Products Sales, by Application Unit (2021-2026)
  • Table 367. France Blood Products Sales, by End-User Unit (2021-2026)
  • Table 368. Italy Blood Products Sales, by Type Unit (2021-2026)
  • Table 369. Italy Blood Products Sales, by Application Unit (2021-2026)
  • Table 370. Italy Blood Products Sales, by End-User Unit (2021-2026)
  • Table 371. United Kingdom Blood Products Sales, by Type Unit (2021-2026)
  • Table 372. United Kingdom Blood Products Sales, by Application Unit (2021-2026)
  • Table 373. United Kingdom Blood Products Sales, by End-User Unit (2021-2026)
  • Table 374. Netherlands Blood Products Sales, by Type Unit (2021-2026)
  • Table 375. Netherlands Blood Products Sales, by Application Unit (2021-2026)
  • Table 376. Netherlands Blood Products Sales, by End-User Unit (2021-2026)
  • Table 377. Rest of Europe Blood Products Sales, by Type Unit (2021-2026)
  • Table 378. Rest of Europe Blood Products Sales, by Application Unit (2021-2026)
  • Table 379. Rest of Europe Blood Products Sales, by End-User Unit (2021-2026)
  • Table 380. MEA Blood Products Sales, by Country Unit (2021-2026)
  • Table 381. MEA Blood Products Sales, by Type Unit (2021-2026)
  • Table 382. MEA Blood Products Sales, by Application Unit (2021-2026)
  • Table 383. MEA Blood Products Sales, by End-User Unit (2021-2026)
  • Table 384. Middle East Blood Products Sales, by Type Unit (2021-2026)
  • Table 385. Middle East Blood Products Sales, by Application Unit (2021-2026)
  • Table 386. Middle East Blood Products Sales, by End-User Unit (2021-2026)
  • Table 387. Africa Blood Products Sales, by Type Unit (2021-2026)
  • Table 388. Africa Blood Products Sales, by Application Unit (2021-2026)
  • Table 389. Africa Blood Products Sales, by End-User Unit (2021-2026)
  • Table 390. North America Blood Products Sales, by Country Unit (2021-2026)
  • Table 391. North America Blood Products Sales, by Type Unit (2021-2026)
  • Table 392. North America Blood Products Sales, by Application Unit (2021-2026)
  • Table 393. North America Blood Products Sales, by End-User Unit (2021-2026)
  • Table 394. United States Blood Products Sales, by Type Unit (2021-2026)
  • Table 395. United States Blood Products Sales, by Application Unit (2021-2026)
  • Table 396. United States Blood Products Sales, by End-User Unit (2021-2026)
  • Table 397. Canada Blood Products Sales, by Type Unit (2021-2026)
  • Table 398. Canada Blood Products Sales, by Application Unit (2021-2026)
  • Table 399. Canada Blood Products Sales, by End-User Unit (2021-2026)
  • Table 400. Mexico Blood Products Sales, by Type Unit (2021-2026)
  • Table 401. Mexico Blood Products Sales, by Application Unit (2021-2026)
  • Table 402. Mexico Blood Products Sales, by End-User Unit (2021-2026)
  • Table 403. Blood Products: by Type(USD/Units)
  • Table 404. Research Programs/Design for This Report
  • Table 405. Key Data Information from Secondary Sources
  • Table 406. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Products: by Type USD Million (2015-2020)
  • Figure 5. Global Blood Products: by Application USD Million (2015-2020)
  • Figure 6. Global Blood Products: by End-User USD Million (2015-2020)
  • Figure 7. South America Blood Products Share (%), by Country
  • Figure 8. Asia Pacific Blood Products Share (%), by Country
  • Figure 9. Europe Blood Products Share (%), by Country
  • Figure 10. MEA Blood Products Share (%), by Country
  • Figure 11. North America Blood Products Share (%), by Country
  • Figure 12. Global Blood Products: by Type Unit (2015-2020)
  • Figure 13. Global Blood Products: by Application Unit (2015-2020)
  • Figure 14. Global Blood Products: by End-User Unit (2015-2020)
  • Figure 15. South America Blood Products Share (%), by Country
  • Figure 16. Asia Pacific Blood Products Share (%), by Country
  • Figure 17. Europe Blood Products Share (%), by Country
  • Figure 18. MEA Blood Products Share (%), by Country
  • Figure 19. North America Blood Products Share (%), by Country
  • Figure 20. Global Blood Products: by Type USD/Units (2015-2020)
  • Figure 21. Global Blood Products share by Players 2020 (%)
  • Figure 22. Global Blood Products share by Players (Top 3) 2020(%)
  • Figure 23. Global Blood Products share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Baxter (United States) Revenue, Net Income and Gross profit
  • Figure 26. Baxter (United States) Revenue: by Geography 2020
  • Figure 27. CSL (Australia) Revenue, Net Income and Gross profit
  • Figure 28. CSL (Australia) Revenue: by Geography 2020
  • Figure 29. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 30. Grifols (Spain) Revenue: by Geography 2020
  • Figure 31. Octapharma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Octapharma (Switzerland) Revenue: by Geography 2020
  • Figure 33. BPL (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. BPL (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Kedrion (ITALY) Revenue, Net Income and Gross profit
  • Figure 36. Kedrion (ITALY) Revenue: by Geography 2020
  • Figure 37. Mitsubishi Tanabe (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Mitsubishi Tanabe (Japan) Revenue: by Geography 2020
  • Figure 39. CBOP (India) Revenue, Net Income and Gross profit
  • Figure 40. CBOP (India) Revenue: by Geography 2020
  • Figure 41. Hualan Bio (China) Revenue, Net Income and Gross profit
  • Figure 42. Hualan Bio (China) Revenue: by Geography 2020
  • Figure 43. Global Blood Products: by Type USD Million (2021-2026)
  • Figure 44. Global Blood Products: by Application USD Million (2021-2026)
  • Figure 45. Global Blood Products: by End-User USD Million (2021-2026)
  • Figure 46. South America Blood Products Share (%), by Country
  • Figure 47. Asia Pacific Blood Products Share (%), by Country
  • Figure 48. Europe Blood Products Share (%), by Country
  • Figure 49. MEA Blood Products Share (%), by Country
  • Figure 50. North America Blood Products Share (%), by Country
  • Figure 51. Global Blood Products: by Type Unit (2021-2026)
  • Figure 52. Global Blood Products: by Application Unit (2021-2026)
  • Figure 53. Global Blood Products: by End-User Unit (2021-2026)
  • Figure 54. South America Blood Products Share (%), by Country
  • Figure 55. Asia Pacific Blood Products Share (%), by Country
  • Figure 56. Europe Blood Products Share (%), by Country
  • Figure 57. MEA Blood Products Share (%), by Country
  • Figure 58. North America Blood Products Share (%), by Country
  • Figure 59. Global Blood Products: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Baxter (United States)
  • CSL (Australia)
  • Grifols (Spain)
  • Octapharma (Switzerland)
  • BPL (United Kingdom)
  • Kedrion (ITALY)
  • Mitsubishi Tanabe (Japan)
  • CBOP (India)
  • Hualan Bio (China)
Select User Access Type

Key Highlights of Report


Nov 2021 202 Pages 65 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Products Quantitative research analysis
Global Blood Products Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Blood Products Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global Blood Products market is dominated by Global Players to generate healthy valuation by 2026.
Companies that are profiled in Global Blood Products Market are Baxter (United States), CSL (Australia), Grifols (Spain), Octapharma (Switzerland), BPL (United Kingdom), Kedrion (ITALY), Mitsubishi Tanabe (Japan), CBOP (India) and Hualan Bio (China) etc.

Know More About Global Blood Products Report?

Have a Query? Click Here

Other Related Reports

Wound Care Biologics Comprehensive Study by Type (Biologic Skin Substitutes (Human Donor Tissue-derived Products, Acellular animal-derived Products, Biosynthetic Products), Topical Agents), Wound (Ul...
$ 3750
Pneumonia Therapeutics Comprehensive Study by Type (Vaccines, Anti-Infectives, Oxygen Therapy), Application (Hospital, Clinic, Medical Center, Other), Pneumonia Types (Hospital-acquired pneumonia (HA...
$ 3650
Bone Morphogenetic Protein Comprehensive Study by Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2, Recombinant Human Bone Morphogenetic Protein (rhBMP) -7), Application (Spinal Fusion,...
$ 3350
Spasticity Treatment Comprehensive Study by Type (Physical Treatment, Medicine Treatment), Application (Children, Adults), End User (Hospital, Research Laboratories, Others) Players and Region - Glob...
$ 3500
Tuberculosis Drug Comprehensive Study by Type (First-line Anti-TB Drugs, Second-line Anti-TB Drugs), Application (Active TB, Latent TB), End User (Hospital, Clinic, Durgstore), Testing (TB skin test ...
$ 3350
Inflammatory Bowel Disease Comprehensive Study by Type (Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory drugs (NSAIDs), Corticosteroids), Application (Hospital, Drugs Stores), Route of A...
$ 3450